Treatment of branch retinal arterial occlusion with sodium ozagrel, a thromboxane A2 synthetase inhibitor

Journal of International Medical Research

Volumn 25, Issue 2, 1997, Pages 108-111

  Kato, H ^a   Emura, S ^a   Takeuchi, N ^a   Enoki, M ^a   Oogushi, K ^a   Takashima, T ^a   Ohmori, K ^a   Saito, I ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Retinal arterial occlusion; Sodium ozagrel; Thromboxane A2

Indexed keywords

BETA THROMBOGLOBULIN; OZAGREL; THROMBOCYTE FACTOR 4; THROMBOXANE SYNTHASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; RETINA ARTERY OCCLUSION; THROMBOSIS; VISUAL FIELD DEFECT;

EID: 0030891226     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059702500208     Document Type: Article

References (10)

1. Newell FW: Opthalmology. Principles and concepts, 4th edn. Saint Louis: The CV Mosby Company, 1978; pp 333 - 335.
2. Mangat HS: Retinal artery occlusion. Surv Ophthalmol 1995; 40: 145 - 156.
3. Knoop K, Trott A: Ophthalmologic procedures in the emergency department - Part I: Immediate sight-saving procedures. Acad Emerg Med 1994; 1: 408 - 412.
4. Reichel E: Vitreoretinal emergencies. Am Fam Physician 1995; 52: 1415 - 1419.
5. Needleman PA, Raz JA, Ferrendelli JA, et al: Application of imidazole as a selective inhibitor of thromboxane synthetase in human platelets. Proc Natl Acad Sci USA 1977; 74: 1716 - 1720.
6. 2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-Propenoic acid (OKY-046). Jpn J Pharmacol 1986; 41: 393 - 401.
7. Naito J, Komatsu H, Ujiie A, et al: Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. Eur J Pharmacol 1983; 91: 41 - 48.
8. Ohtomo E, Kutsuzawa T, Kogure K, et al: Clinical usefulness of OKY-046 on the acute stage of cerebral thrombosis. Double-blind trial in comparison with placebo (in Japanese, English abstract). J Clin Ther Med 1991; 7: 353 - 388.
9. Suzuki S, Iwabuchi T, Tanaka T, et al: Prevention of cerebral vasospasm with OKY-046 an imidazole derivative and a thromboxane synthetase inhibitor. A preliminary co-operative clinical study. Acta Neurochir 1985; 77: 133 - 141.
10. Tokiyoshi K, Ohnishi T, Nu Y: Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surg Neurol 1991; 36: 112 - 118.